Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
;
(12): 1174-1177, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-669194
ABSTRACT
Objective:
To evaluate therapeutic effects and adverse reactions of tocilizumab on patients with severe active rheumatoid arthritis (RA).Methods:
Twelve patients with severe refractory RA were treated with tocilizumab.The clinical and laboratory indices and the side effects were recorded after treatment.Results:
The clinical and laboratory indices and the disease activity score 28 (DAS28) were observed in all patients,which were significantly improved after TCZ therapy (P<0.05),and no obvious adverse reactions were found.Conclusion:
Tocilizumab can effectively relieve the symptoms and improve the conditions of severe active RA.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Central South University(Medical Sciences)
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS